Ascend Capital’s Calithera Biosciences CALA Stock Holding History
Bought
Maintained
Sold
Other funds holding CALA
Ascend Capital's CALA Position: Q3 2018 in Review
Ascend Capital reduced its Calithera Biosciences (CALA) stake by 88% in Q3 2018, selling an estimated $960K and leaving 1,321 shares worth $138K. The position accounts for 0.01% of the portfolio, ranked #163.
Ascend Capital first reported a position in CALA in Q2 2017 and has held it in 6 quarters since. The position peaked at $10.4M in Q3 2017. 81 funds tracked by Wall St. Rank hold CALA as of Q3 2018.
- Ascend Capital held 1,321 shares of Calithera Biosciences worth $138K as of Q3 2018.
- Ascend Capital sold 10,084 Calithera Biosciences shares in Q3 2018, an estimated $960K.
- Calithera Biosciences made up 0.01% of Ascend Capital's portfolio in Q3 2018, its #163 holding.
- Ascend Capital first reported a position in Calithera Biosciences in Q2 2017 and has held it in 6 quarters since.
- Ascend Capital's Calithera Biosciences position peaked at $10.4M in Q3 2017.
- 81 funds tracked by Wall St. Rank held Calithera Biosciences as of Q3 2018.
Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.